[1] WU H, LIU Y, SHU XO, et al.MiR-374a suppresses lung adenocarcinoma cell proliferation and invasion by targeting TGFA gene expression[J].Carcinogenesis, 2016, 37(6):567. doi: 10.1093/carcin/bgw038
[2] XU Z, XU Z, XU J, et al.LARP1 is regulated by the XIST/miR-374a axis and functions as an oncogene in non-small cell lung carcinoma[J].Oncol Rep, 2017, 38(6):3659.
[3] LU T, ZHANG C, CHAI MX, et al.MiR-374a promotes the proliferation of osteosarcoma cell proliferation by targeting Axin2[J].Int J Clin Exp Pathol, 2015, 8(9):10776.
[4] WANG Y, XIN H, HAN Z, et al.MicroRNA-374a promotes esophageal cancer cell proliferation via Axin2 suppression[J].Oncol Rep, 2015, 34(4):1988. doi: 10.3892/or.2015.4182
[5] XIONG Y, QIU J, LI C, et al.Fortunelin-induced modulation of phosphatase and tensin homolog by microRNA-374a decreases inflammation and maintains intestinal barrier function in colitis[J].Front Immunol, 2018, 9(83):1.
[6] GONG W, QIE S, HUANG P, et al.Protective effect of mir-374a on chemical hypoxia-induced damage of PC12 cells in vitro via the GADD45α/JNK signaling pathway[J].Neurochem Res, 2017, 43(3):581.
[7] RAN FA, HSE PD, WRIGHT J, et al.Genome engineering using the CRISPR-Cas9 system[J].Nat Protoc, 2013, 8(11):2281. doi: 10.1038/nprot.2013.143
[8] GAJ T, GERSBACH CA, BARBAS CF 3rd.ZFN, TALEN and CRISPR/Cas-based methods for genome engineering[J].Trends Biotechnol, 2013, 31(7):397. doi: 10.1016/j.tibtech.2013.04.004